This was supported in another study, where cisplatin resistant NSCLC cells also had increased glucose uptake in vitro and in vivo compared to sensitive NSCLC cells, which could be abrogated through HK2 inhibition (He and Liu, 2020). Here, HK2 is linked to non-small cell lung carcinoma.